Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ex-Moore Trader Leslie to Close JCAM Global, Launch New Fund

James Caird Asset Management, a firm that is run by Tim Leslie, a former trader at Louis Bacon’s Moore Capital Management, announced this week that he would be liquidating his $1.6 billion hedge fund, JCAM Global Fund, after eight years reports Bloomberg.  He plans to start giving investors their money back starting in January.

“I have been frustrated by our performance during the current year,” said Leslie. MOORE GLOBAL INVESTMENTS

The fund lost 8.9 percent from January 1 through the end of November, compared to an average hedge fund loss of -3.8 percent for the same period. Bloomberg reports, “Leslie attributed the losses to poor liquidity and the unfolding crisis in financial markets. He said the lack of market liquidity is ‘structural’ and not something that will go away any time soon. As a result, he plans to start a smaller hedge fund with a narrower trading focus.” The new fund will launch in 2012 and be managed by Robert Miller. Miller has worked with Leslie since 2003. Leslie is looking to raise $500 million for the new fund and intends to cap levels at about that level.

Leslie launched the JCAM Global Fund in 2003, while he was still employed at Moore Capital. Leslie didn’t leave Moore Capital until 2008, when he devoted his time entirely to running his fund. According to Bloomberg, Moore is an investor in Leslie’s JCAN fund.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!